10. Drug allergy.
暂无分享,去创建一个
[1] S. Spielberg,et al. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.
[2] G. Beall,et al. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. , 1994, The Journal of allergy and clinical immunology.
[3] J. Nelson,et al. Management of heparin allergy in pregnancy , 2001, American journal of hematology.
[4] I. Moll,et al. Management of insulin allergy , 2001, Allergy. European Journal of Allergy and Clinical Immunology.
[5] H. S. Earl,et al. Studies of human IgE to a sulfonamide determinant. , 1987, The Journal of allergy and clinical immunology.
[6] R. Lawrence,et al. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. , 1996, The Pediatric infectious disease journal.
[7] R. Moscicki,et al. Adverse reactions to heparin. , 1990, Annals of allergy.
[8] R. Simon,et al. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. , 2001, The Journal of allergy and clinical immunology.
[9] P. Gell,et al. Clinical aspects of immunology , 1968 .
[10] H. Wedner,et al. Skin testing to detect penicillin allergy. , 1981, The Journal of allergy and clinical immunology.
[11] B. Baldo,et al. Penicillins and cephalosporins as allergens — structural aspects of recognition and cross‐reactions , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[12] C. Katlama,et al. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. , 1997, Archives of dermatology.
[13] O. Idsøe,et al. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. , 1968, Bulletin of the World Health Organization.
[14] L. Rybicki,et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] M. Relling,et al. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia , 1998, Leukemia.
[16] M. Fischl,et al. Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] K. Arndt,et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. , 1986, JAMA.
[18] M. Markman,et al. Prevention and Management of Antineoplastic-Induced Hypersensitivity Reactions , 2001, Drug safety.
[19] H. Hori,et al. Rapid desensitization for L-asparaginase hypersensitivity. , 1998, The Journal of allergy and clinical immunology.
[20] B. Levine,et al. Minor haptenic determinant-specific reagins of penicillin hypersensitivity in man. , 1969, International archives of allergy and applied immunology.
[21] C. Ritchlin,et al. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. , 2001, Archives of dermatology.
[22] P. Woster,et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. , 2000, The Journal of investigative dermatology.
[23] S. Knowles,et al. Anticonvulsant Hypersensitivity Syndrome , 1999, Drug safety.
[24] H. Jick,et al. Assessment of adverse reactions within a drug surveillance program. , 1968, JAMA.
[25] W. Lorenz,et al. Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent , 1977, Agents and Actions.
[26] L. C. Sweet,et al. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy. , 1977, The Journal of allergy and clinical immunology.
[27] J. Sastre,et al. Lack of allergic cross‐reactivity to cephalosporins among patients allergic to penicillins , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] A. Neugut,et al. Anaphylaxis in the United States: an investigation into its epidemiology. , 2001, Archives of internal medicine.
[29] N. Adkinson,et al. Immediate hypersensitivity reactions to penicillin and related antibiotics , 1988, Clinical allergy.
[30] W. Pichler,et al. Role of T cells in drug allergies , 1998, Allergy.
[31] J. Roujeau,et al. Physiopathology and treatment of severe drug eruptions , 2001, Current opinion in allergy and clinical immunology.
[32] R. Gruchalla. Acute drug desensitization. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[33] L. Lichtenstein,et al. Routine use of penicillin skin testing on an inpatient service. , 1971, The New England journal of medicine.
[34] P. Fritsch,et al. Delayed‐Type Hypersensitivity and Cross‐Reactivity to Heparins and Danaparoid: A Prospective Study , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[35] B. Leyland-Jones,et al. Hypersensitivity reactions to teniposide (VM-26): an analysis. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] I. Bernstein,et al. Disease management of drug hypersensitivity: A practice parameter: Preface , 1999 .
[37] S. Spielberg,et al. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[38] E. Pratt,et al. Localized insulin allergy treated with continuous subcutaneous insulin , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[39] Fusco,et al. Carboplatin hypersensitivity reactions in patients with ovarian and peritoneal carcinoma , 1998 .
[40] R. Reisman,et al. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[41] H. Friedman,et al. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. , 1996, Medical and pediatric oncology.
[42] Wan Ariffin Bin Abdullah,et al. Med Pediatr Oncol , 1999 .
[43] R. Gelber,et al. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to escherichia coli asparaginase , 1992, Cancer.
[44] D. Davies,et al. Textbook of Adverse Drug Reactions , 1992, Annals of Internal Medicine.
[45] P. Lieberman,et al. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin. , 1994, The Journal of allergy and clinical immunology.
[46] R. Valenta,et al. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. , 2000, The Journal of allergy and clinical immunology.
[47] S. Oka,et al. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[48] M. Markman,et al. Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] W. Pichler,et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. , 2000, The Journal of allergy and clinical immunology.
[50] C. Bayerl,et al. Association of heparin‐induced skin lesions, intracutaneous tests, and heparin‐induced IgG , 1999, Allergy.
[51] J. Bousquet,et al. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. , 1998, The Journal of allergy and clinical immunology.
[52] B. Levine. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. , 1966, The New England journal of medicine.
[53] M. Markowitz. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever , 1991 .
[54] G. Kearns,et al. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. , 1994, The Journal of pediatrics.
[55] R. Lin. A perspective on penicillin allergy. , 1992, Archives of internal medicine.
[56] J B Vermorken,et al. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] R. Gruchalla,et al. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. , 1991, The Journal of allergy and clinical immunology.
[58] E. Middleton,et al. Allergy, principles and practice , 1978 .
[59] R. Patterson,et al. Drug allergy and protocols for management of drug allergies. , 1995, Allergy proceedings : the official journal of regional and state allergy societies.
[60] M. Laxenaire. Épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996) , 1999 .
[61] T. Casale,et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. , 1992, Archives of internal medicine.
[62] P. Gorevic,et al. Desensitization of anaphylactic hypersensitivity specific for the penicilloate minor determinant of penicillin and carbenicillin. , 1981, The Journal of allergy and clinical immunology.
[63] D. Skiest,et al. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole. , 1998, The Journal of allergy and clinical immunology.
[64] N. Adkinson,et al. DIAGNOSTIC TESTING FOR DRUG HYPERSENSITIVITY , 1998, Radiologic Clinics of North America.
[65] Dominic P. Williams,et al. Reactive metabolites and their role in drug reactions , 2001, Current opinion in allergy and clinical immunology.
[66] M. Pirmohamed,et al. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation in vivo , 2001, British journal of pharmacology.
[67] J. Rich,et al. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[68] M Pirmohamed,et al. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity , 1999, British journal of pharmacology.
[69] Pumphrey. Lessons for management of anaphylaxis from a study of fatal reactions , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[70] C. W. Parker,et al. Drug allergy (first of three parts). , 1975, The New England journal of medicine.
[71] R. Nicklas. The diagnosis and management of anaphylaxis , 2005 .
[72] C. Pui,et al. Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia , 1991, Cancer.